Otsuka Co. (OTCMKTS:OSUKF – Get Free Report) was the target of a significant decline in short interest during the month of August. As of August 31st, there was short interest totaling 694,393 shares, a decline of 39.9% from the August 15th total of 1,155,521 shares. Based on an average daily trading volume, of 2 shares, the short-interest ratio is presently 347,196.5 days.
Otsuka Price Performance
OSUKF opened at $20.00 on Friday. Otsuka has a 12-month low of $19.00 and a 12-month high of $21.57. The firm’s fifty day moving average price is $20.10 and its 200 day moving average price is $20.52.
Otsuka Company Profile
Otsuka Holdings Co, Ltd., traded as OSUKF on the OTC Market, is a global healthcare group headquartered in Tokyo, Japan. The company operates through its principal subsidiary, Otsuka Pharmaceutical Co, Ltd., and is primarily engaged in the research, development and commercialization of pharmaceutical products and nutraceuticals. Its product portfolio spans central nervous system therapies, cardiovascular and metabolic treatments, nephrology, and oncology, alongside a range of consumer wellness goods such as nutritional beverages and dietary supplements.
The origins of the Otsuka group date back to 1921 with the founding of its predecessor firm, and in 2008 the current holding company structure was established to streamline governance and strategic direction.
Featured Stories
- Five stocks we like better than Otsuka
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
